Drug discovery for overcoming chronic kidney disease (CKD): pharmacological effects of mineralocorticoid-receptor blockers.
about
Budget impact analysis of chronic kidney disease mass screening test in Japan.Mitochondrial reactive oxygen species-mediated NLRP3 inflammasome activation contributes to aldosterone-induced renal tubular cells injury.Introduction: hearing footsteps of the future.Antihypertensive and cardiorenal protective effects of SM-368229, a novel mineralocorticoid receptor antagonist, in aldosterone/salt-treated rats.
P2860
Drug discovery for overcoming chronic kidney disease (CKD): pharmacological effects of mineralocorticoid-receptor blockers.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Drug discovery for overcoming ...... locorticoid-receptor blockers.
@en
type
label
Drug discovery for overcoming ...... locorticoid-receptor blockers.
@en
prefLabel
Drug discovery for overcoming ...... locorticoid-receptor blockers.
@en
P2093
P356
P1476
Drug discovery for overcoming ...... locorticoid-receptor blockers.
@en
P2093
Akira Nishiyama
Asadur Rahman
Hideyasu Kiyomoto
Hirofumi Hitomi
P356
10.1254/JPHS.08R12FM
P577
2009-01-01T00:00:00Z